Published in J Thromb Haemost on July 01, 2006
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrob Agents Chemother (1998) 3.60
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet (2007) 2.50
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost (2006) 2.22
Massive pulmonary embolism leading to cardiac arrest is associated with consumptive coagulopathy presenting as disseminated intravascular coagulation. J Thromb Haemost (2010) 1.60
Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther (1999) 1.50
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. J Thromb Haemost (2012) 1.48
Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther (2000) 1.46
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood (2000) 1.45
Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes. J Thromb Haemost (2006) 1.43
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins. Clin Pharmacol Ther (1994) 1.40
Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost (2007) 1.10
Heparin blunts endotoxin-induced coagulation activation. Circulation (2000) 1.09
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost (2006) 1.09
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion (2001) 1.05
Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration. Clin Pharmacokinet (2001) 1.03
Effects of low dose endotoxemia on endothelial progenitor cells in humans. Atherosclerosis (2007) 1.02
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost (2010) 1.01
Sex differences in HAART-associated dyslipidaemia. AIDS (2001) 1.00
Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. Am J Clin Pathol (1996) 1.00
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost (2009) 0.97
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Vaccine (2008) 0.95
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. J Infect Dis (2008) 0.94
Racial differences in endotoxin-induced tissue factor-triggered coagulation. J Thromb Haemost (2009) 0.93
Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Invest (2009) 0.93
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab (1997) 0.92
Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost (1999) 0.91
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost (2000) 0.91
A newly developed precise and sensitive radioimmunoassay for clonidine. Arzneimittelforschung (1979) 0.90
Lepirudin blunts endotoxin-induced coagulation activation. Blood (2000) 0.89
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma. J Thromb Haemost (2012) 0.89
Role of von Willebrand factor in vascular disease. Hamostaseologie (2009) 0.89
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation (1997) 0.88
Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies. Thromb Haemost (2001) 0.87
Low-dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol (1998) 0.86
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. Am J Hypertens (1999) 0.86
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen. Arterioscler Thromb Vasc Biol (1999) 0.85
Development of a RIA for clonidine and its comparison with the reference methods. J Pharmacol Methods (1981) 0.85
Impaired platelet function among platelet donors. Thromb Haemost (2001) 0.83
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology (2001) 0.83
Plasma levels of activated factor VII decrease during the menstrual cycle. Thromb Haemost (1998) 0.83
High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol (2001) 0.83
Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man. Atherosclerosis (2000) 0.83
Circadian rhythms of rabbits during restrictive feeding. Am J Physiol (1987) 0.83
Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest (1998) 0.82
Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia. Int J Immunopathol Pharmacol (2007) 0.82
The internal synchronization of five circadian functions of the rabbit. Chronobiol Int (1984) 0.81
Restricted food access and light-dark: impact of conflicting zeitgebers on circadian rhythms of the rabbit. Am J Physiol (1993) 0.81
Development and quality control of a highly sensitive radioimmunoassay for alinidine. J Pharmacol Methods (1981) 0.81
The effect of plasma removal from apheresis platelet concentrates on platelet function. Vox Sang (2011) 0.81
Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils. J Infect Dis (2000) 0.80
Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. Clin Pharmacokinet (2001) 0.80
Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol (2009) 0.80
Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100. Br J Haematol (2000) 0.79
Strain differences in toxic effects of long-lasting isoflurane anaesthesia between Wistar rats and Sprague Dawley rats. Food Chem Toxicol (2008) 0.79
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. Can J Physiol Pharmacol (1996) 0.79
Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr Eye Res (1997) 0.79
Endotoxemia enhances circulating endothelial cells in humans. J Thromb Haemost (2006) 0.79
Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin. Int J Clin Pharmacol Ther (2010) 0.79
Long QT syndrome associated with inflammatory degeneration of the stellate ganglia. Clin Cardiol (1989) 0.79
Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert's syndrome by genotyping UGT1A1*28 promoter polymorphism. Int J Clin Pharmacol Ther (2002) 0.79
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens (2012) 0.78
Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin. Thromb Res (1997) 0.78
Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin. Transfusion (1998) 0.78
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans. Eur J Clin Invest (2003) 0.78
Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism. Eur Respir J (2009) 0.78
Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100. J Thromb Haemost (2004) 0.78
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings. Thromb Res (1997) 0.78
Sex differences in circulating P-selectin, E-selectin and thrombomodulin. Br J Haematol (1996) 0.78
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery. Clin Exp Immunol (2015) 0.78
Man, mouse and Duffy genotype-phenotype-specific pharmacokinetics of monocyte chemotactic protein-1. Transfus Med (2004) 0.78
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. Int J Clin Pharmacol Ther (2005) 0.77
Regional cortical development in very low birth weight infants with normal neurodevelopmental outcome assessed by 3D-ultrasound. J Perinatol (2012) 0.77
Effects of anticoagulation on thrombopoietin release during endotoxemia. J Lab Clin Med (2001) 0.77
Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation. Thromb Res (2000) 0.77
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. AIDS (1999) 0.77
Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men. Atherosclerosis (2001) 0.77
Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C. Aliment Pharmacol Ther (2005) 0.77
Detecting aspirin resistance with the platelet function analyzer (PFA-100). Am J Cardiol (2001) 0.76
Potential biomarkers of an exaggerated response to endotoxemia. Biomarkers (2007) 0.76
Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis. Br J Haematol (1998) 0.76
Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis. Transfusion (1998) 0.76
Dexamethasone downregulates L-selectin in vitro and in vivo. Circulation (1998) 0.75
Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men. Arterioscler Thromb Vasc Biol (1997) 0.75
Granulocyte colony-stimulating factor and cytokine release. Clin Pharmacol Ther (2000) 0.75
Soluble P-selectin in diabetes. Thromb Haemost (1999) 0.75
Chemistry, pharmacology, and structure-activity relationships with a new type of imidazolines exerting a specific bradycardic action at a cardiac site. J Med Chem (1980) 0.75
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation. Clin Pharmacol Ther (2007) 0.75
[Arrhythmogenic effects of anti-arrhythmia agents]. Z Gesamte Inn Med (1987) 0.75
Anterograde conduction of a concealed accessory pathway after transvenous electric catheter ablation. Clin Cardiol (1986) 0.75
Delayed effect of desmopressin on circulating neutrophils and monocytes. Br J Haematol (1996) 0.75
The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references. Int J Clin Pharmacol Ther (2008) 0.75
[Differential therapeutic problems in sinus node syndrome--drug or electrical therapy?]. Z Gesamte Inn Med (1986) 0.75
Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.75
The on column methylation of clonidine and p-hydroxyclonidine with trimethylanilinium hydroxide. Biomed Mass Spectrom (1978) 0.75
[Transvascular intracardiac ablation--on the current status of the method in the treatment of tachyarrhythmias]. Z Gesamte Inn Med (1987) 0.75